491 related articles for article (PubMed ID: 37855910)
1. Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways.
Postwala H; Shah Y; Parekh PS; Chorawala MR
Med Oncol; 2023 Oct; 40(11):334. PubMed ID: 37855910
[TBL] [Abstract][Full Text] [Related]
2. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.
Coppedè F; Lopomo A; Spisni R; Migliore L
World J Gastroenterol; 2014 Jan; 20(4):943-56. PubMed ID: 24574767
[TBL] [Abstract][Full Text] [Related]
3. The role of epigenetics in colorectal cancer.
Coppedè F
Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):935-48. PubMed ID: 24871610
[TBL] [Abstract][Full Text] [Related]
4. JMJD2C promotes colorectal cancer metastasis via regulating histone methylation of MALAT1 promoter and enhancing β-catenin signaling pathway.
Wu X; Li R; Song Q; Zhang C; Jia R; Han Z; Zhou L; Sui H; Liu X; Zhu H; Yang L; Wang Y; Ji Q; Li Q
J Exp Clin Cancer Res; 2019 Oct; 38(1):435. PubMed ID: 31665047
[TBL] [Abstract][Full Text] [Related]
5. Assimilating Epigenetics and Transcriptomics for the Identification of Prognostic Novel Biomarkers and Imminent Targets in Colorectal Carcinoma with Therapeutic Potential.
Ray SK; Mukherjee S
Curr Mol Med; 2023; 23(8):784-798. PubMed ID: 35546765
[TBL] [Abstract][Full Text] [Related]
6. Exploring Potential Epigenetic Biomarkers for Colorectal Cancer Metastasis.
Ajithkumar P; Vasantharajan SS; Pattison S; McCall JL; Rodger EJ; Chatterjee A
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255946
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicine.
Fatemi N; Tierling S; Es HA; Varkiani M; Mojarad EN; Aghdaei HA; Walter J; Totonchi M
Int J Cancer; 2022 Dec; 151(12):2068-2081. PubMed ID: 35730647
[TBL] [Abstract][Full Text] [Related]
8. Insulin-Like Growth Factor 2 (IGF2) Signaling in Colorectal Cancer-From Basic Research to Potential Clinical Applications.
Kasprzak A; Adamek A
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31623387
[TBL] [Abstract][Full Text] [Related]
9. Dietary phytochemicals in colorectal cancer prevention and treatment: A focus on the molecular mechanisms involved.
Afrin S; Giampieri F; Gasparrini M; Forbes-Hernández TY; Cianciosi D; Reboredo-Rodriguez P; Zhang J; Manna PP; Daglia M; Atanasov AG; Battino M
Biotechnol Adv; 2020; 38():107322. PubMed ID: 30476540
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic biomarkers in colorectal cancer diagnostics.
Rawson JB; Bapat B
Expert Rev Mol Diagn; 2012 Jun; 12(5):499-509. PubMed ID: 22702366
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer epigenetics: complex simplicity.
van Engeland M; Derks S; Smits KM; Meijer GA; Herman JG
J Clin Oncol; 2011 Apr; 29(10):1382-91. PubMed ID: 21220596
[TBL] [Abstract][Full Text] [Related]
12. Role of gut microbiota in epigenetic regulation of colorectal Cancer.
Zhao Y; Wang C; Goel A
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188490. PubMed ID: 33321173
[TBL] [Abstract][Full Text] [Related]
13. Are Wnt/β-Catenin and PI3K/AKT/mTORC1 Distinct Pathways in Colorectal Cancer?
Prossomariti A; Piazzi G; Alquati C; Ricciardiello L
Cell Mol Gastroenterol Hepatol; 2020; 10(3):491-506. PubMed ID: 32334125
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic-based therapy for colorectal cancer: Prospect and involved mechanisms.
Rezapour S; Hosseinzadeh E; Marofi F; Hassanzadeh A
J Cell Physiol; 2019 Nov; 234(11):19366-19383. PubMed ID: 31020647
[TBL] [Abstract][Full Text] [Related]
15. Emerging role of PI3K/AKT in tumor-related epigenetic regulation.
Yang Q; Jiang W; Hou P
Semin Cancer Biol; 2019 Dec; 59():112-124. PubMed ID: 30951826
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic Biomarkers in Colorectal Cancer.
Verma M; Kumar V
Mol Diagn Ther; 2017 Apr; 21(2):153-165. PubMed ID: 27878475
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer: Genetic alterations, novel biomarkers, current therapeutic strategies and clinical trials.
Housini M; Dariya B; Ahmed N; Stevens A; Fiadjoe H; Nagaraju GP; Basha R
Gene; 2024 Jan; 892():147857. PubMed ID: 37783294
[TBL] [Abstract][Full Text] [Related]
18. Epigenetics of colorectal cancer: biomarker and therapeutic potential.
Jung G; Hernández-Illán E; Moreira L; Balaguer F; Goel A
Nat Rev Gastroenterol Hepatol; 2020 Feb; 17(2):111-130. PubMed ID: 31900466
[TBL] [Abstract][Full Text] [Related]
19. Advances in epigenetic biomarker research in colorectal cancer.
Wang X; Kuang YY; Hu XT
World J Gastroenterol; 2014 Apr; 20(15):4276-87. PubMed ID: 24764665
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of aberrant DNA methylation during colorectal cancer development.
Sakai E; Nakajima A; Kaneda A
World J Gastroenterol; 2014 Jan; 20(4):978-87. PubMed ID: 24574770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
